Detecting Auricular Points in MMG by a Novel APD ( APD-MMG ) (NCT03702114) | Clinical Trial Compass
UnknownNot Applicable
Detecting Auricular Points in MMG by a Novel APD ( APD-MMG )
Hong Kong24 participantsStarted 2018-10-15
Plain-language summary
This pilot study is designed to validate the diagnostic ability of a novel APD for auricular point detection among patients with menstrual migraine (MMG), as compared with an already commercialized device.
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* When attacks, average migraine pain severity \>=5 point measured by a 10-point VAS scale;
* Diagnosed pure menstrual migraine without aura or menstrually related migraine without aura according to The International Classification of Headache Disorders: 2nd edition;
* Provide written inform consent;
* Free of any other diagnosed psychological conditions;
Exclusion Criteria:
* with any other diseases such as cardiovascular, renal, neurological, digestive, hepatic, respiratory disease
* Pregnancy or lactation
* Participation in a clinical study that may interfere with participation in this study
* History of or current tobacco, alcohol use
* Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study
* Unable to provide written informed consent due to any reason.